Primary brain amyloidoma, both a neoplastic and a neurodegenerative disease: a case report.
Amyloidoma
Brain tumor
Neurodegenerative disease
Neurooncology
Neurovascular unit
Journal
BMC neurology
ISSN: 1471-2377
Titre abrégé: BMC Neurol
Pays: England
ID NLM: 100968555
Informations de publication
Date de publication:
10 Apr 2019
10 Apr 2019
Historique:
received:
25
07
2018
accepted:
18
03
2019
entrez:
12
4
2019
pubmed:
12
4
2019
medline:
22
5
2019
Statut:
epublish
Résumé
Scattered extracellular deposits of amyloid within the brain parenchyma can be found in a heterogeneous group of diseases. Its condensed accumulation in the white matter without evidence for systemic amyloidosis is known as primary brain amyloidoma (PBA). Although originally considered as a tumor-like lesion by its space-occupying effect, this condition displays also common hallmarks of a neurodegenerative disorder. A 50-year-old woman presented with a mild cognitive decline and seizures with a right temporal, irregular and contrast-enhancing mass on magnetic resonance imaging. Suspecting a high-grade glioma, the firm tumor was subtotally resected. Neuropathological examination showed no glioma, but distinct features of a neurodegenerative disorder. The lesion was composed of amyloid AL λ aggregating within the brain parenchyma as well as the adjacent vessels, partially obstructing the vascular lumina. Immunostaining confirmed a distinct perivascular inflammatory reaction. After removal of the PBA, mnestic impairments improved considerably, the clinical course and MRI-results are stable in the 8-year follow-up. Based on our histopathological findings, we propose to regard the clinicopathological entity of PBA as an overlap between a neoplastic and neurodegenerative disorder. Since the lesions are locally restricted, they might be amenable to surgery with the prospect of a definite cure.
Sections du résumé
BACKGROUND
BACKGROUND
Scattered extracellular deposits of amyloid within the brain parenchyma can be found in a heterogeneous group of diseases. Its condensed accumulation in the white matter without evidence for systemic amyloidosis is known as primary brain amyloidoma (PBA). Although originally considered as a tumor-like lesion by its space-occupying effect, this condition displays also common hallmarks of a neurodegenerative disorder.
CASE PRESENTATION
METHODS
A 50-year-old woman presented with a mild cognitive decline and seizures with a right temporal, irregular and contrast-enhancing mass on magnetic resonance imaging. Suspecting a high-grade glioma, the firm tumor was subtotally resected. Neuropathological examination showed no glioma, but distinct features of a neurodegenerative disorder. The lesion was composed of amyloid AL λ aggregating within the brain parenchyma as well as the adjacent vessels, partially obstructing the vascular lumina. Immunostaining confirmed a distinct perivascular inflammatory reaction. After removal of the PBA, mnestic impairments improved considerably, the clinical course and MRI-results are stable in the 8-year follow-up.
CONCLUSION
CONCLUSIONS
Based on our histopathological findings, we propose to regard the clinicopathological entity of PBA as an overlap between a neoplastic and neurodegenerative disorder. Since the lesions are locally restricted, they might be amenable to surgery with the prospect of a definite cure.
Identifiants
pubmed: 30971206
doi: 10.1186/s12883-019-1274-x
pii: 10.1186/s12883-019-1274-x
pmc: PMC6458836
doi:
Types de publication
Case Reports
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
59Références
Arch Neurol. 2005 Mar;62(3):477-80
pubmed: 15767515
Clin Lymphoma Myeloma. 2005 Nov;6(3):208-19
pubmed: 16354326
Arch Neurol. 2006 Jun;63(6):906-7
pubmed: 16769875
Amyloid. 2007 Mar;14(1):11-9
pubmed: 17453621
Arch Neurol. 2008 Jul;65(7):979-80
pubmed: 18625871
Proc Natl Acad Sci U S A. 2009 Jan 27;106(4):1261-6
pubmed: 19164591
J Neuropathol Exp Neurol. 2009 Mar;68(3):286-99
pubmed: 19225408
Cell Mol Life Sci. 2010 Feb;67(4):581-600
pubmed: 19898742
Clin Neuropathol. 2010 Jul-Aug;29(4):217-22
pubmed: 20569671
Acta Neuropathol. 2011 Apr;121(4):431-43
pubmed: 21259015
Ups J Med Sci. 2012 May;117(2):244-50
pubmed: 22335280
Neurology. 2013 Oct 29;81(18):1596-603
pubmed: 24078731
Neuron. 2013 Nov 20;80(4):844-66
pubmed: 24267647
J Neurol Sci. 2015 Dec 15;359(1-2):404-8
pubmed: 26476773
Lancet. 2016 Jun 25;387(10038):2641-2654
pubmed: 26719234
Brain Pathol. 2018 Mar;28(2):234-239
pubmed: 28160367
Circ Res. 2017 Jul 21;121(3):258-269
pubmed: 28515043
Neuron. 2017 Sep 27;96(1):17-42
pubmed: 28957666
Acta Neuropathol. 1988;76(2):212-5
pubmed: 3407399
J Neurosurg. 1982 Mar;56(3):439-42
pubmed: 7057245
Cancer. 1998 Jan 15;82(2):362-74
pubmed: 9445195